Depression
Conditions
Interventions
experimental group:Intradermal needle
Sponsors
Nuclear Industry 416th Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria for novel coronavirus infection and the diagnosis of sequelae of novel coronavirus; (2) In line with the diagnostic criteria for depression; 7=HAMA-17=24 min; (3) Age 18-70 years old, male or female; (4) did not receive acupuncture, drugs and other antidepressant treatment within 2 months before the intervention; (5) Patients with clear consciousness, no barriers in autonomous activities, no barriers in reading or understanding ability, and who can cooperate with the completion of scoring and follow-up during the study; (6) Sign informed consent.
Exclusion criteria
Exclusion criteria: (1) Those who do not meet the diagnostic criteria and inclusion criteria; (2) Pregnant or lactating women; (3) Patients who have been diagnosed with anxiety, depression and other psychiatric diseases or have been taking psychiatric drugs; (4) Patients with major organic diseases or critical conditions; (5) previous suicidal tendencies, schizophrenia, bipolar disorder or other mental disorders; (6) A history of alcohol or drug abuse. Note: If one of the criteria is met, it will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hamilton depression scale-17,HAMD-17; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pittsburgh sleep quality index, PSQI;Glutamate, Glu;Gamma-Aminobutyric Acid, GABA; | — |
Countries
China
Contacts
Public ContactLi Tao
Nuclear Industry 416th Hospital
Outcome results
None listed